Best Practices Review of Algorithmic-Based Assays that Include NAAT for the Diagnosis of C. difficile
Title:Best Practices Review of Algorithmic-Based Assays that Include NAAT for the Diagnosis of C.difficile
Date: Thursday, August 29
Time: 1:00 p.m. ET
Presenter: James Snyder, PhD
Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.
An Expert Perspective
Increases in reported C. difficile infections (CDI) have highlighted diagnostic protocols and initiatives that aim to reduce overcalling of the disease. In this P.A.C.E.-accredited Fisher Healthcare webinar, James Snyder, PhD, will share his expert perspective on the recently updated ASM C. difficile infection guidelines. He will also review IDSA guidelines and other clinical evidence that describes the analytical and clinical utility of diagnostic tests and protocols for C. difficile.
Learning Objectives
This webinar will help you:
- Summarize the latest ASM C. difficile guidelines
- Discuss IDSA guidelines and how guidelines fit into clinical diagnosis
- Review analytical detection versus clinical diagnosis
- Describe other diagnostic test methods, including EIA, PCR, and other molecular methods
This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E. Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.
Presenters
James Snyder, PhD
Dr. Snyder is a professor in the Department of Pathology and Laboratory Medicine and the Chief of Microbiology at the University of Louisville Hospital. He earned his PhD in biology (medical microbiology) at the University of Dayton.
Dr. Snyder serves as a representative of the American Society for Microbiology to the Association of Public Health Laboratories (APHL) Working Group for Response to Bioterrorism and Emerging Diseases, as well as the coordinator of the Sentinel Level Laboratory Protocols for Biothreat and Emerging Infectious Diseases. He is a member of the American Society for Microbiology’s Laboratory Practices Committee as well as the society’s Expert Panel for the Development of Evidence-Based Laboratory Guidelines.